Analytical Ultracentrifugation (AUC) Hydrodynamic Lab

Model matrix-free sedimentation velocity, Lamm equation boundary transport, c(s) distribution deconvolution, AAV full/empty capsids, and testing facility cash flows.

First-Principles Hydrodynamics 10-Yr DCF Model
Centrifugal Field
181,000 × g
Mid-Cell Acceleration
Primary Peak (s₁)
70%
Full Capsid / Monomer
Secondary Peak (s₂)
30%
Empty Capsid / Dimer
Sedimentation Rate
95.0 S
1 S = 10⁻¹³ s
Facility 10-Yr NPV
$1,485,200
10% WACC
Internal IRR
79.2%
Payback: 1.3 yrs

Ultracentrifuge Controls

Lamm Solver
Rotor Speed: 20,000 RPM
Primary Coefficient (s₁): 95.0 S
Primary Species Fraction: 70%
Secondary Coefficient (s₂): 60.5 S
Rotor Chamber Temperature: 20.0 °C
Partial Specific Volume (v̄): 0.710 mL/g

Testing Facility DCF Economics

Optima AUC Platform CapEx: $340,000
Annual AUC Analytical Runs: 900
Testing Fee / Sample: $380

Sedimentation Velocity Radial Scans: A(r, t)

Time-resolved radial boundaries sedimenting from meniscus (5.92 cm) to cell bottom (7.18 cm)
Lamm Transport
Svedberg equation: s = (1/ω²r)(dr/dt) Radial dilution: plateau depletes as (rm / rb)² in sector cells

Continuous Sedimentation Coefficient Distribution: c(s)

First-principles deconvolution resolving AAV full/empty capsids or antibody oligomers
Matrix-Free Deconvolution
Peak areas represent absolute molar/weight fractions without column matrix artifacts 1 Svedberg = 10⁻¹³ seconds sedimentation velocity per acceleration unit

5-Year AUC Testing Facility Cash Flow Schedule

Period Revenue OpEx EBITDA Free Cash Flow Discounted FCF

1. Matrix-Free First-Principles Characterization

Analytical Ultracentrifugation (AUC) is the recognized gold standard for macromolecular biophysics because it operates entirely without solid matrices:

  • No Stationary Phase or Column Shearing: Unlike Size-Exclusion Chromatography (SEC), macromolecules remain in free solution, preventing matrix adsorption, dissociation of reversible oligomers, or shear degradation.
  • First-Principles Thermodynamics: Particle sedimentation velocities depend strictly on molar mass ($M$), buoyant density ($1 - \bar{v}\rho$), and frictional drag coefficient ($f$).
  • Multi-Wavelength Optical Detection: Simultaneous UV/Vis absorbance and Rayleigh laser interference optics record radial scans across the entire cell length.

2. AAV Gene Therapy: Full vs Empty Capsid Quantification

In viral vector gene therapy, AUC is the mandatory reference standard for quantifying capsid packaging purity:

  • Full Capsids (~95S): Contain the therapeutic single-stranded DNA payload, increasing buoyant mass and accelerating sedimentation.
  • Empty Capsids (~60S): Protein shells lacking genome, sedimenting much slower due to lower density and buoyant mass.
  • Partial/Intermediate Capsids (~70–80S): Resolving truncated genome fragments, which cannot be separated by standard optical or chromatographic methods.

3. Lamm Equation & Continuous c(s) Deconvolution

Modern numerical analysis converts raw radial scans into continuous sedimentation distributions:

  • Lamm Equation Transport: Models simultaneous centrifugal sedimentation and backward diffusional dispersion across sector-shaped cells.
  • Radial Dilution Effect: Divergent cell centerpieces cause solution volume to expand radially, depleting plateau concentration as $(r_m / r_b)^2$.
  • Continuous $c(s)$ Inversion: Maximum entropy and non-linear least squares deconvolve diffusion broadening to produce sharp, baseline-resolved Svedberg peaks.

4. Testing Facility Economics & DCF Valuation

Contract analytical laboratories and biopharma characterization cores generate exceptional economic returns with AUC:

  • Capital Expenditure: State-of-the-art analytical ultracentrifuges (e.g., Beckman Coulter Optima AUC) require \$300,000 to \$380,000 CapEx.
  • Premium Service Pricing: Due to extreme regulatory demand for gene therapy lot release, testing fees range from \$350 to \$450 per sample run.
  • Compelling Financial Returns: Annual testing volumes of 800 to 1,000 runs produce over \$340,000 in gross revenue, achieving full capital payback within 1.3 years and internal rates of return near 80%.

Frequently Asked Questions: Analytical Ultracentrifugation

Analytical Ultracentrifugation (AUC) is the definitive matrix-free, first-principles physical technique for characterizing macromolecules and colloidal nanoparticles in native solution. By subjecting samples to intense centrifugal gravitational fields (up to 250,000 x g at 60,000 RPM) while continuously recording UV/Vis absorbance or Rayleigh interference optical scans across radial positions, AUC measures sedimentation and diffusion rates without column matrices, membranes, or calibration standards.

In gene therapy, adeno-associated virus (AAV) manufacturing produces both therapeutic capsids packaged with viral DNA genome (Full, ~95S) and empty protein shells lacking DNA (Empty, ~60S). While Size Exclusion Chromatography (SEC) cannot resolve full from empty capsids due to identical hydrodynamic size, AUC separates them with unmatched resolution based strictly on buoyant mass density from first principles, making it the primary orthogonal release standard required by regulatory agencies (FDA/EMA).

Sedimentation Velocity (SV) operates at high rotor speeds where sedimentation strongly dominates diffusion, tracking moving boundary fronts over time to determine hydrodynamic size, shape, and continuous c(s) sedimentation coefficient distributions. Sedimentation Equilibrium (SE) operates at lower speeds where centrifugal transport is exactly balanced by backward diffusional flux, forming a time-invariant concentration gradient from which absolute molecular weight is derived directly without frictional coefficient assumptions.

AUC sample centerpiece cavities are manufactured as radially divergent sectors radiating outward from the rotor center of rotation. As particles sediment outward toward the cell bottom, the cross-sectional area of the sector expands proportionally with radius (r). Consequently, the concentration of the sedimenting plateau decreases following the square of the radial position ratio: c(t) = c0 * (rm / r_boundary)^2.

Modern multi-wavelength AUC systems (e.g., Beckman Coulter Optima AUC) represent capital investments around $300,000 to $380,000, along with quartz optical windows, titanium centerpieces, and vacuum maintenance. Specialized analytical testing facilities charge premium rates of $350 to $450 per sample. With annual throughput of 800 to 1,000 runs supporting biopharma lot release and gene therapy IND filings, contract laboratories generate over $340,000 in gross revenue, achieving capital payback in approximately 1.2 to 1.4 years.

Knowledge Check: AUC Hydrodynamics & Gene Therapy

Related Biophysical & Molecular Metrology Tools